Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06871774 · ClinicalTrials.gov registry record · NA
Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR
A NA study of Transcatheter Aortic Valve Replacement, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06871774: Recruiting NA study of Transcatheter Aortic Valve Replacement, sponsored by Wake Forest University Health Sciences.
NCT06871774 is a NA study of Transcatheter Aortic Valve Replacement that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06871774, a NA study of Transcatheter Aortic Valve Replacement, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the use of one Perclose device to the usual approach of two devices for pre-closure during Transcatheter Aortic Valve Replacement (TAVR). The study will compare the time it takes for bleeding to stop using the different closure approaches. The study will also compare complications when using one Perclose device versus two.
Primary Outcome
Number of subjects in each group experiencing major or minor vascular complications directly related to the TAVR procedure occurring during the index hospitalization.
Conditions Studied
Interventions
- DEVICE Single Perclose Pro vascular closure device
- DEVICE Dual Perclose vascular closure device
Study Locations (1)
Wisconsin
- Aurora St. Luke's Medical Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-06-16 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT06871774 shows while recruiting
NCT06871774 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Transcatheter Aortic Valve Replacement appearing as the primary indexed condition, and to 2 interventions - of which Single Perclose Pro vascular closure device is the first listed.
NCT06871774 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06871774 about?
NCT06871774 is a clinical study titled "Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR". This study will compare the use of one Perclose device to the usual approach of two devices for pre-closure during Transcatheter Aortic Valve Replacement (TAVR). The study will compare the time it takes for bleeding to stop using the different closure approaches. The study will also compare complica...
What is the current status of trial NCT06871774?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-06-16. Estimated completion is 2026-07.
What conditions does trial NCT06871774 study?
This clinical trial studies the following conditions: Transcatheter Aortic Valve Replacement.
What interventions are being tested in trial NCT06871774?
The interventions under investigation include: Single Perclose Pro vascular closure device (DEVICE), Dual Perclose vascular closure device (DEVICE).
Who is sponsoring clinical trial NCT06871774?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06871774 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transcatheter Aortic Valve Replacement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06871774's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI